- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01607411
A Clinical Study to Evaluate Experimental Children's Toothpastes in an In-Situ Caries Model
August 7, 2014 updated by: GlaxoSmithKline
An in situ model will be used to evaluate and compare enamel remineralization of human enamel specimens after single use of experimental children's toothpastes.
Study Overview
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Indiana University School of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years to 14 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy males and females aged 11 to 14 inclusive who have an unstimulated salivary flow rate of at least 0.2 mL/minute and a stimulated salivary flow rate of at least 0.8 mL/minute (Screening Visit 1).
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Fluoride free toothpaste
toothpaste with no fluoride
|
Fluoride free toothpaste
|
|
Experimental: 1426ppm Fluoride Toothpaste
Experimental toothpaste containing 1426 ppm Fluoride
|
Fluoride Toothpaste
|
|
Experimental: 1000 ppm Fluoride Toothpaste
Experimental toothpaste containing 1000 ppm Fluoride
|
Fluoride Toothpaste
|
|
Experimental: 500 ppm Toothpaste
Experimental toothpaste containing 500 ppm Fluoride
|
Fluoride Toothpaste
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage Surface Microhardness Recovery of Test Dentifrices Relative to Placebo Dentifrice
Time Frame: Baseline to 4 hours
|
Surface microhardness recovery (SMHR) test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester.
SMHR was determined by measuring the length of the indentations of enamel specimens.
An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface.
Percent SMHR was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first demineralization challenge (D1) using formula: [(D1-R)/ (D1-B)]*100.
|
Baseline to 4 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
%SMHR of Enamel Specimens Exposed to Test Treatments
Time Frame: Baseline to 4 hours
|
Surface microhardness recovery (SMHR) test was used to assess the changes in mineralization status of enamel specimens using a Wilson 2100 Hardness tester.
SMHR was determined by measuring the length of the indentations of enamel specimens.
An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface.
Percent SMHR was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first demineralization challenge (D1) using formula: [(D1-R)/ (D1-B)]*100.
|
Baseline to 4 hours
|
|
Percent Net Acid Resistance (%NAR) of Enamel Specimens
Time Frame: Baseline to 4 hours
|
Changes in mineral content of enamel specimens exposed to dietary erosive challenge were determined by measuring the length of the indentations.
Decrease in the indentation length compared to the baseline indicates hardening of enamel surface.
Enamel specimens were exposed to second erosion challenge to determine NAR which compared the indentations values of sound enamel specimens at baseline (B), first demineralization challenge (D1) and second demineralization challenge (D2).
Percent NAR was calculated by formula: [(D1-D2)/ (D1-B)]*100.
|
Baseline to 4 hours
|
|
Enamel Fluoride Uptake
Time Frame: Baseline to 4 hours
|
Enamel fluoride uptake was determined using the microdrill enamel biopsy technique.
The amount of fluoride uptake by enamel was calculated based on amount of F divided by volume of the enamel cores and expressed as micrograms (μg)* F/centimeters(cm)^2. Difference between treatments was calculated with respect to F uptake by enamel.
|
Baseline to 4 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
February 16, 2012
First Submitted That Met QC Criteria
May 24, 2012
First Posted (Estimate)
May 30, 2012
Study Record Updates
Last Update Posted (Estimate)
August 11, 2014
Last Update Submitted That Met QC Criteria
August 7, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RH01390
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.